Latest Chemotherapy regimens Stories
SAN FRANCISCO, Dec.
Given that patients with relapsed aggressive non-Hodgkin's lymphoma are poorly served by current therapies, a significant unmet need exists in this setting.
SEATTLE, Nov. 3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
By Eric Eyre For years, cancer patients have complained about the memory loss and attention problems they experience while undergoing chemotherapy.
By HELEN PUTTICK HEALTH CORRESPONDENT DRUGS to help battle cancer were approved for use by the NHS in Scotland yesterday.
Aveo Pharmaceuticals has started another Phase Ib clinical study for its lead product candidate, the triple VEGF receptor inhibitor AV-951.
A Japanese-led study suggests an experimental combination of chemotherapy agents might be a good alternative to standard lung cancer treatment.
SEATTLE, Aug. 5 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company") (Nasdaq: CTIC; MTA) t announced that Craig W. Philips has assumed his role as CTI's new President, and will concentrate on managing the company's drug development and commercial operations.
BETHLEHEM, Pa., June 23 /PRNewswire/ -- A new blood test may make it easier for oncologists to accurately measure and personalize 5-fluorouracil (5-FU) dosing for patients undergoing continuous infusion chemotherapy regimens.
Researchers from the Indiana University School of Medicine and the Purdue School of Science at Indiana University-Purdue University Indianapolis have created the first three-dimensional image of how a well-established chemotherapy agent targets and binds to DNA.
- In medieval musical notation, a sign or neume denoting a shake or trill.